elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q47213188-83C4B40A-E323-4F21-B20A-3517206F7C17
Q47213188-83C4B40A-E323-4F21-B20A-3517206F7C17
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47213188-83C4B40A-E323-4F21-B20A-3517206F7C17
Effectiveness of biosimilar filgrastim vs. original granulocyte colony-stimulating factors in febrile neutropenia prevention in breast cancer patients.
P2860
Q47213188-83C4B40A-E323-4F21-B20A-3517206F7C17
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47213188-83C4B40A-E323-4F21-B20A-3517206F7C17
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1663a1600a4fcb0c4ba0feb961dc11973672a9c0
P2860
XM02 is superior to placebo and equivalent to Neupogen in reducing the duration of severe neutropenia and the incidence of febrile neutropenia in cycle 1 in breast cancer patients receiving docetaxel/doxorubicin chemotherapy.